share_log

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga ·  Apr 2 08:07

Gainers

  • MSP Recovery (NASDAQ:LIFW) stock increased by 61.9% to $1.08 during Tuesday's pre-market session. The company's market cap stands at $15.9 million.
  • Serina Therapeutics (AMEX:SER) stock moved upwards by 28.33% to $15.18. The company's market cap stands at $152.5 million.
  • CareMax (NASDAQ:CMAX) stock moved upwards by 18.49% to $5.83. The company's market cap stands at $22.1 million.
  • Imunon (NASDAQ:IMNN) stock rose 16.58% to $2.25. The company's market cap stands at $21.1 million. As per the press release, Q4 earnings came out 3 days ago.
  • Mira Pharmaceuticals (NASDAQ:MIRA) shares rose 12.96% to $1.22. The market value of their outstanding shares is at $18.0 million. As per the news, the Q4 earnings report came out yesterday.
  • ThermoGenesis Holdings (NASDAQ:THMO) shares moved upwards by 11.86% to $0.8. The company's market cap stands at $2.5 million.

Losers

  • Acorda Therapeutics (NASDAQ:ACOR) stock declined by 75.1% to $3.36 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.1 million. As per the news, the Q4 earnings report came out yesterday.
  • Gritstone Bio (NASDAQ:GRTS) stock fell 40.01% to $1.41. The company's market cap stands at $138.2 million.
  • Verve Therapeutics (NASDAQ:VERV) shares fell 34.72% to $8.35. The market value of their outstanding shares is at $698.2 million.
  • Petros Pharma (NASDAQ:PTPI) stock declined by 28.58% to $1.0. The company's market cap stands at $2.2 million. As per the news, the Q4 earnings report came out yesterday.
  • Avalo Therapeutics (NASDAQ:AVTX) shares fell 19.61% to $14.39. The market value of their outstanding shares is at $11.5 million.
  • Aclarion (NASDAQ:ACON) stock declined by 16.27% to $0.34. The company's market cap stands at $2.4 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment